Skip to main content
Article
Endocrine effects of IL-1α and β administered in a phase I trial to patients with advanced cancer
Journal of Immunotherapy (1996)
  • Brendan D. Curti, National Institutes of Health
  • Walter J. Urba, Providence Portland Medical Center
  • Dan L. Longo, National Institutes of Health
  • John E. Janik, National Institutes of Health
  • William H. Sharfman, National Institutes of Health
  • Langdon L. Miller, National Institutes of Health
  • Giovanni Cizza, National Institutes of Health
  • Masanao Shimizu
  • Joost J. Oppenheim, National Institutes of Health
  • W. Gregory Alvord, National Institutes of Health
  • John W. Smith, National Institutes of Health
Publication Date
January 3, 1996
DOI
10.1097/00002371-199603000-00007
Citation Information
Brendan D. Curti, Walter J. Urba, Dan L. Longo, John E. Janik, et al.. "Endocrine effects of IL-1α and β administered in a phase I trial to patients with advanced cancer" Journal of Immunotherapy Vol. 19 Iss. 2 (1996) p. 142 - 148
Available at: http://works.bepress.com/walter-urba/245/